
8. juni 2010:Pressemeddelelse nr. 5, 2010: Zealand Pharma Announces An Extension of The Lixisenatide...
The 31st European Peptide Symposium, Copenhagen, Denmark, 5-9 September 2010 (Science) 46th An...
8. juni 2010:
Pressemeddelelse nr. 5, 2010: Zealand Pharma Announces An Extension of The Lixisenatide Global Licensing Agreement with sanofi-aventis for Type-2 Diabetes
6 May 2010:
Press Release no. 4, 2010: Annual Review for 2009
15 April 2010:
Press Release no. 3, 2010: Positive Phase III Diabetes Data with Lixisenatide Announced by Zealand Pharma’s Partner sanofi-aventis
8 Marts 2010:
Press Release no. 2, 2010: Zealand Pharma Announces Augmentation of its Management Team as it Continues its Growth Strategy
2 Marts 2010:
Press Release no. 1, 2010: Zealand Pharma and PolyTherics enter Collaboration Agreement for novel optimised biopharmaceuticals
Home Legal Disclaimer Updated: 27.7.2010